Lipfendra with Ongoing Care
Lipfendra blocks PCSK9, helping the liver retain LDL receptors that remove LDL cholesterol from the blood. This oral treatment is approved alongside diet and exercise for adults with high LDL cholesterol, including heterozygous familial hypercholesterolemia. Your clinician determines whether it fits your lipid-management plan. Available through Healthspan Membership with clinician-led evaluation and ongoing care. Your clinician determines whether this treatment is appropriate; a prescription is not guaranteed.
Care through Healthspan Membership
Membership is $99 per month, billed $297 every three months. Receive biomarker testing through your membership, care-team guidance, and access to prescription evaluation for cholesterol management. Your clinician reviews your history and results to determine which treatment, if any, is appropriate.